Results
|
|
501.
|
Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib. [electronic resource] by
- Zhu, Xingmei
- Wu, Lin
- Qiao, Hongyu
- Han, Tenglong
- Chen, Suning
- Liu, Xueying
- Jiang, Ru
- Wei, Yifang
- Feng, Dayun
- Zhang, Yuan
- Ma, Yongzheng
- Zhang, Shengyong
- Zhang, Jian
Producer: 20140506
In:
Journal of cellular biochemistry vol. 114
Availability: No items available.
|
|
|
502.
|
|
|
|
503.
|
Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases. [electronic resource] by
- Parsai, Shireen
- Miller, Jacob A
- Juloori, Aditya
- Chao, Samuel T
- Kotecha, Rupesh
- Mohammadi, Alireza M
- Ahluwalia, Manmeet S
- Murphy, Erin S
- Barnett, Gene H
- Vogelbaum, Michael A
- Angelov, Lilyana
- Peereboom, David M
- Suh, John H
Producer: 20200421
In:
Journal of neurosurgery vol. 132
Availability: No items available.
|
|
|
504.
|
A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies. [electronic resource] by
- Lynce, Filipa
- Wang, Hongkun
- Petricoin, Emanuel F
- Pohlmann, Paula R
- Smaglo, Brandon
- Hwang, Jimmy
- He, Aiwu R
- Subramaniam, Deepa S
- Deeken, John
- Marshall, John
- Pishvaian, Michael J
Producer: 20200519
In:
Cancer chemotherapy and pharmacology vol. 84
Availability: No items available.
|
|
|
505.
|
|
|
|
506.
|
Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancer. [electronic resource] by
- LoRusso, Patricia M
- Jones, Suzanne F
- Koch, Kevin M
- Arya, Nikita
- Fleming, Ronald A
- Loftiss, Jill
- Pandite, Lini
- Gadgeel, Shirish
- Weber, Barbara L
- Burris, Howard A
Producer: 20080708
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26
Availability: No items available.
|
|
|
507.
|
|
|
|
508.
|
|
|
|
509.
|
|
|
|
510.
|
|
|
|
511.
|
|
|
|
512.
|
|
|
|
513.
|
Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer. [electronic resource] by
- Cha, Yongjun
- Han, Sae-Won
- Seol, Hyesil
- Oh, Do-Youn
- Im, Seock-Ah
- Bang, Yung-Jue
- Park, In Ae
- Han, Wonshik
- Noh, Dong-Young
- Kim, Tae-You
Producer: 20141111
In:
Anticancer research vol. 34
Availability: No items available.
|
|
|
514.
|
|
|
|
515.
|
FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation. [electronic resource] by
- Park, Jinju
- Choi, Yiseul
- Ko, Young San
- Kim, Younghoon
- Pyo, Jung-Soo
- Jang, Bo Gun
- Kim, Min A
- Lee, Jae-Seon
- Chang, Mee Soo
- Park, Jong-Wan
- Lee, Byung Lan
Producer: 20180816
In:
Cancer research and treatment vol. 50
Availability: No items available.
|
|
|
516.
|
|
|
|
517.
|
|
|
|
518.
|
|
|
|
519.
|
|
|
|
520.
|
Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. [electronic resource] by
- Karajannis, Matthias A
- Legault, Geneviève
- Hagiwara, Mari
- Ballas, Marc S
- Brown, Krysten
- Nusbaum, Annette O
- Hochman, Tsivia
- Goldberg, Judith D
- Koch, Kevin M
- Golfinos, John G
- Roland, J Thomas
- Allen, Jeffrey C
Producer: 20130117
In:
Neuro-oncology vol. 14
Availability: No items available.
|